Compositions and methods for monitoring the modification state of a pair of polypeptides

• US 7,166,475 B2
• Filed: 02/26/1999
• Issued: 01/23/2007
• Est. Priority Date: 02/26/1999
• Status: Expired due to Fees

• Current Assignee: Cyclacel Pharmaceuticals Incorporated
• Original Assignee: Cyclacel Pharmaceuticals Incorporated
• Inventors: Craig, Roger K., Colyer, John, Mezna, Mokdad, Maschio, Antonio
• Primary Examiner(s): Navarro; Mark
• Assistant Examiner(s): PORTNER, VIRGINIA ALLEN
• Application Number:
  US09/259,658
• Publication Number:
  US 20030032054A1
• Time in Patent Office: 2,888 Days
• Field of Search: 435/6, 435/69.1, 435/193, 435/320.1, 435/7.2, 435/15, 435/7.1, 435/4, 435/63, 435/64, 435/7.4, 435/21, 435/7.8, 435/254.21, 435/29, 435/7.9, 435/7.71, 435/7.72, 435/7.7, 435/194, 435/188, 530/350, 530/387.3, 536/235, 436/537, 436/544, 436/546
• US Class Current: 436/518
• CPC Class Codes: C12Q 1/37 involving peptidase or proteinase
• CPC Class Codes: C12Q 1/42 involving phosphatase
• CPC Class Codes: C12Q 1/485 involving kinase
• CPC Class Codes: G01N 2500/02 Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
• CPC Class Codes: G01N 33/54306 Solid-phase reaction mechanisms

Abstract

This invention relates to a method for analyzing a sample comprising: immobilising a polypeptide to a physical support; contacting the immobilised polypeptide with a test sample which may contain an agent capable of modifying the immobilised polypeptide; contacting the immobilised polypeptide with a binding partner polypeptide, wherein the binding of this partner polypeptide to the immobilised polypeptide is at least partly dependent on the modification state of the immobilised polypeptide; and measuring the association of the binding partner polypeptide to the immobilised polypeptide.

Claims

1. A method for detecting, in a sample, the presence of a modifying enzyme which covalently modifies a polypeptide, the method comprising the steps of:

a) providing a polypeptide pair comprising a first polypeptide and a second, binding partner polypeptide, capable of associating with said first polypeptide, wherein said second, binding partner polypeptide is not a phospho-specific antibody, and wherein the association of the polypeptides is detectable, and covalent modification of at least one of the polypeptides results in modulation of the association and wherein said covalent modification comprises one of the group consisting of phosphorylation, acylation, glycosylation, ubiquitination, prenylation, sentrinization, and ADP-ribosylation;

b) providing a modifying group substrate, wherein said substrate, in the presence of a modifying enzyme, results in the covalent modification of said first polypeptide or said second binding partner polypeptide;

c) immobilizing the first polypeptide to a physical plasmon resonance support;

d) contacting said immobilized polypeptide and said second binding partner polypeptide in the presence of said sample and said modifying group substrate; and

e) measuring the association of the second, binding partner polypeptide to the first polypeptide, thereby determining the covalent modification of at least one of said polypeptides, whereby the presence of said modifying enzyme is detected;

wherein said association is measured by monitoring the molecular mass of the binding partner by surface plasmon resonance.

2. A method for detecting, in a sample, the presence of a modifying enzyme which covalently modifies a polypeptide, the method comprising the steps of:

a) providing a polypeptide pair comprising a first polypeptide and a second, binding partner polypeptide, capable of associating with said first polypeptide, wherein said second, binding partner polypeptide is not a phospho-specific antibody, and wherein the association of the polypeptides is detectable, and covalent modification of at least one of the polypeptides results in modulation of the association and wherein said covalent modification comprises one of the group consisting of phosphorylation, acylation, glycosylation, ubiquitination, prenylation, sentrinization, and ADP-ribosylation;

b) providing a modifying group substrate, wherein said substrate, in the presence of a modifying enzyme, results in the covalent modification of said first polypeptide or said second binding partner polypeptide;

c) immobilizing the first polypeptide to a physical support;

d) contacting said immobilized polypeptide and said second binding partner polypeptide in the presence of said sample and said modifying group substrate; and

e) measuring the association of the second, binding partner polypeptide to the first polypeptide, thereby determining the covalent modification of at least one of said polypeptides, whereby the presence of said modifying enzyme is detected;

wherein said association is measured by monitoring the molecular mass of the binding partner by scintillation proximity assay.

3. A method for detecting, in a sample, the presence of a modifying enzyme which covalently modifies a polypeptide, the method comprising the steps of:

a) providing a polypeptide pair comprising a first polypeptide and a covalently modified second, binding partner polypeptide capable of associating with said first polypeptide, wherein said second, binding partner polypeptide is not a phospho-specific antibody, and wherein said association of the polypeptides is detectable, and wherein removal of the covalent modification from said second, binding partner polypeptide by a modifying enzyme results in modulation of the association and wherein said covalent modification comprises one of the group consisting of phosphorylation, acylation, glycosylation, ubiquitination, prenylation, sentrinization, and ADP-ribosylation;

b) immobilizing the first polypeptide to a physical plasmon resonance support;

c) contacting said immobilized polypeptide and said second binding partner polypeptide in the presence of said sample; and

d) measuring the association of the second, binding partner polypeptide to the first polypeptide, thereby determining the removal of said covalent modification from said second binding partner polypeptide, whereby the presence of said modifying enzyme is detected;

wherein said association is measured by monitoring the molecular mass of the binding partner by surface plasmon resonance.

4. A method for detecting, in a sample, the presence of a modifying enzyme which covalently modifies a polypeptide, the method comprising the steps of:

a) providing a polypeptide pair comprising a first polypeptide and a covalently modified second, binding partner polypeptide capable of associating with said first polypeptide, wherein said second, binding partner polypeptide is not a phospho-specific antibody, and wherein said association of the polypeptides is detectable, and wherein removal of the covalent modification from said second, binding partner polypeptide by a modifying enzyme results in modulation of the association and wherein said covalent modification comprises one of the group consisting of phosphorylation, acylation, glycosylation, ubiquitination, prenylation, sentrinization, and ADP-ribosylation;

b) immobilizing the first polypeptide to a physical support;

c) contacting said immobilized polypeptide and said second binding partner polypeptide in the presence of said sample; and

d) measuring the association of the second, binding partner polypeptide to the first polypeptide, thereby determining the removal of said covalent modification from said second binding partner polypeptide, whereby the presence of said modifying enzyme is detected;

wherein said association is measured by monitoring the molecular mass of the binding partner by scintillation proximity assay.